+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Latent AMR Market - Global Forecast 2026-2032- Product Image
Latent AMR Market - Global Forecast 2026-2032- Product Image
Sale

Latent AMR Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6144640
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Latent AMR Market is projected to reach USD 1.51 Billion in 2026. It is expected to continue growing at a CAGR of 5.63%, reaching USD 2.09 Billion by 2032.

Introduction to Latent AMR

Latent antimicrobial resistance (AMR) refers to resistance that is present but not yet clinically recognized, routinely detected, or fully expressed in surveillance and treatment systems. It can persist in people, animals, food chains, and environmental reservoirs, creating a gap between apparent susceptibility and the risk of treatment failure. Understanding latent AMR requires an integrated view of microbiology, diagnostics, prescribing, infection prevention, agriculture, and wastewater monitoring.

Transformative Shifts in the Latent AMR Landscape

The landscape is shifting from episodic detection toward continuous, One Health surveillance. Genomic sequencing, wastewater sampling, electronic prescribing records, rapid susceptibility testing, and interoperable laboratory systems are improving the ability to identify resistance earlier and trace transmission across settings. At the same time, stewardship is moving beyond hospital-focused interventions toward community care, veterinary medicine, food production, and environmental management. Persistent gaps in laboratory capacity, data sharing, diagnostic access, and responsible antimicrobial use continue to make latent resistance difficult to recognize.

How Artificial Intelligence Is Changing Latent AMR Detection

Artificial intelligence can support latent AMR work by identifying patterns across genomic, clinical, prescribing, laboratory, and environmental datasets. Potential applications include prioritizing samples for testing, detecting unusual resistance signals, predicting resistance phenotypes from sequence data, improving antimicrobial selection, and optimizing surveillance resources. These tools should complement, not replace, laboratory confirmation and clinical judgment. Their reliability depends on representative training data, transparent validation, strong cybersecurity, protection of patient information, and safeguards against bias caused by uneven testing and reporting.

Regional Insights Across the Latent AMR Landscape

North America combines advanced laboratory and genomic capabilities with persistent challenges in healthcare-associated resistance, outpatient prescribing, and cross-border surveillance. Latin America faces uneven diagnostic access and surveillance coverage, while regional collaboration can strengthen monitoring of community, food-chain, and environmental transmission. Europe benefits from coordinated public-health structures, although variation between countries remains important. The Middle East requires stronger integration across healthcare, travel, and antimicrobial stewardship systems. Africa’s priorities include expanding laboratory networks, affordable diagnostics, and surveillance beyond major urban centers. Asia-Pacific contains highly diverse health systems and substantial movement of people, animals, and goods, making interoperable One Health surveillance and antimicrobial stewardship especially important.

Insights Across ASEAN, BRICS, the EU, G7, GCC, and NATO

ASEAN’s interconnected economies and varied health-system capacity create a strong case for shared laboratory standards, cross-border data exchange, and coordinated action on pharmaceutical and agricultural use. BRICS members can contribute complementary strengths in research, manufacturing, surveillance, and public-health delivery, while addressing differences in reporting and diagnostic access. The European Union can leverage coordinated surveillance and regulatory mechanisms, including One Health approaches. G7 countries are positioned to support research, diagnostics, financing, and international standards. GCC states can strengthen regional preparedness through integrated hospital, travel, and food-system surveillance. NATO members can benefit from compatible preparedness protocols that address resistant infections as a health-security concern without displacing civilian public-health governance.

Country Perspectives on Latent AMR Priorities

Australia can build on coordinated surveillance and rural-health capabilities; Brazil should continue integrating public-health, agricultural, and environmental monitoring; Canada can deepen federal, provincial, and territorial data interoperability; and China can expand standardized genomic and clinical surveillance across its large health system. France, Germany, Italy, Spain, and the United Kingdom can further align hospital, community, veterinary, and environmental programs while improving cross-border comparability. India’s priorities include accessible diagnostics, stewardship, and surveillance across diverse care settings. Japan and South Korea can use advanced laboratory and digital infrastructure to strengthen early-warning systems. Mexico can improve connectivity between clinical laboratories and public-health authorities. Russia’s monitoring priorities include laboratory standardization, transparent reporting, and integration across healthcare and environmental domains. The United States can continue linking resistance tracking with antimicrobial stewardship, rapid diagnostics, and One Health surveillance.

Actions for Industry Leaders Addressing Latent AMR

Industry leaders should establish measurable stewardship and infection-prevention objectives across operations and supply chains, then connect those objectives to laboratory-confirmed outcomes. Investments should prioritize rapid, accessible diagnostics, interoperable data systems, genomic and wastewater surveillance, and responsible use of AI under clear validation and governance procedures. Organizations should audit antimicrobial practices, strengthen workforce training, preserve data quality, and collaborate with public-health, veterinary, agricultural, and environmental partners. Procurement and product-development decisions should reward verified surveillance, responsible antimicrobial use, and solutions that improve access without encouraging unnecessary treatment.

Research Methodology for Assessing Latent AMR

A robust assessment combines a structured review of peer-reviewed research, public-health guidance, surveillance reports, laboratory standards, regulatory materials, and One Health evidence. Findings should be triangulated across clinical isolates, genomic data, antimicrobial-use records, wastewater and environmental samples, veterinary observations, and documented diagnostic practices. Regional, group, and country comparisons should account for differences in testing intensity, reporting definitions, healthcare access, laboratory quality, and data completeness. Claims should be retained only when supported by verifiable sources, with uncertainty and methodological limitations stated explicitly.

Conclusion: Making Hidden Resistance Visible

Latent AMR is a systems challenge because resistance can circulate or develop before routine clinical and surveillance processes reveal it. The most effective response combines earlier detection, stronger diagnostics, responsible antimicrobial use, coordinated One Health governance, and carefully controlled use of artificial intelligence. Progress will depend on translating fragmented signals into timely, comparable evidence while maintaining scientific validation, privacy, equity, and accountability across regions and sectors.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Latent AMR Market, by Technology
7.1. Introduction
7.2. Genotypic
7.2.1. Microarray
7.2.2. Ngs
7.2.3. Pcr
7.3. Phenotypic
7.3.1. Automated Systems
7.3.2. Broth Microdilution
7.3.3. Disc Diffusion
8. Latent AMR Market, by Product
8.1. Introduction
8.2. Instruments
8.3. Kits & Reagents
8.4. Software & Services
8.4.1. Consulting Services
8.4.2. Data Analysis Software
8.4.3. Lims
9. Latent AMR Market, by Pathogen
9.1. Introduction
9.2. Bacterial
9.3. Fungal
9.4. Parasitic
9.5. Viral
10. Latent AMR Market, by Workflow
10.1. Introduction
10.2. Analytical
10.3. Post Analytical
10.4. Pre Analytical
11. Latent AMR Market, by Application
11.1. Introduction
11.2. Diagnostics
11.2.1. Clinical
11.2.2. Research
11.3. Drug Discovery & Development
11.4. Surveillance
12. Latent AMR Market, by End User
12.1. Introduction
12.2. Hospitals & Clinics
12.3. Pharmaceutical Companies
12.4. Reference Laboratories
12.5. Research Institutes
13. Latent AMR Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Latent AMR Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Latent AMR Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. ABB Ltd.
17.2. Aclara RF Systems LLC
17.3. Averna Technologies Inc.
17.4. CalAmp Corp.
17.5. Cisco Systems, Inc.
17.6. EDMI Limited
17.7. Elster Group GmbH
17.8. Hexing Electrical Co., Ltd.
17.9. Honeywell International Inc.
17.10. Huawei Technologies Co., Ltd.
17.11. IBM Corporation
17.12. Itron, Inc.
17.13. Kamstrup A/S
17.14. Landis+Gyr Group AG
17.15. Nokia Corporation
17.16. Oracle America, Inc.
17.17. Schneider Electric SE
17.18. Secure Meters Ltd.
17.19. Siemens AG
17.20. Toshiba Digital Solutions Corporation
17.21. Trilliant Holdings Inc.
17.22. Wasion Group Holdings Limited
17.23. Xylem Inc.
17.24. ZTE Corporation
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Latent AMR Market, Years Considered for the Study
FIGURE 2. Global Latent AMR Market, Research Design
FIGURE 3. Global Latent AMR Market, Research Framework
FIGURE 4. Global Latent AMR Market, Data Triangulation
FIGURE 5. Global Latent AMR Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Latent AMR Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 7. Global Latent AMR Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Latent AMR Market Size, by Product, 2025 vs 2032 (%)
FIGURE 9. Global Latent AMR Market Size, by Product, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Latent AMR Market Size, by Pathogen, 2025 vs 2032 (%)
FIGURE 11. Global Latent AMR Market Size, by Pathogen, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Latent AMR Market Size, by Workflow, 2025 vs 2032 (%)
FIGURE 13. Global Latent AMR Market Size, by Workflow, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Latent AMR Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Latent AMR Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Latent AMR Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Latent AMR Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Latent AMR Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Latent AMR Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Latent AMR Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Latent AMR Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Latent AMR Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Latent AMR Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Latent AMR Market Segmentation & Coverage
TABLE 2. Global Latent AMR Market Size, 2017-2032 (USD Million)
TABLE 3. Global Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 4. Global Genotypic Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Genotypic Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Genotypic Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Microarray Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Microarray Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Microarray Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Ngs Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Ngs Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Ngs Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Pcr Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Pcr Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Pcr Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Phenotypic Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Phenotypic Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Phenotypic Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Automated Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Automated Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Automated Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Broth Microdilution Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Broth Microdilution Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Broth Microdilution Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Disc Diffusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Disc Diffusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Disc Diffusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 29. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Kits & Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Kits & Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Kits & Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Software & Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Software & Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Software & Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Consulting Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Consulting Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Consulting Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Data Analysis Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Data Analysis Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Data Analysis Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Lims Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Lims Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Lims Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 48. Global Bacterial Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Bacterial Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Bacterial Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Fungal Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Fungal Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Fungal Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Parasitic Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Parasitic Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Parasitic Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Viral Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Viral Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Viral Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 61. Global Analytical Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Analytical Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Analytical Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Post Analytical Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Post Analytical Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Post Analytical Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Pre Analytical Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Pre Analytical Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Pre Analytical Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 71. Global Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Clinical Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Clinical Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Clinical Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Drug Discovery & Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Drug Discovery & Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Drug Discovery & Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Surveillance Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Surveillance Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Surveillance Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 87. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Reference Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Reference Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Reference Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Latent AMR Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Latent AMR Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. North America Latent AMR Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. North America Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 113. North America Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 114. North America Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 115. North America Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 116. North America Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 117. North America Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 118. North America Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 119. North America Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 120. North America Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 121. North America Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. Latin America Latent AMR Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Latin America Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 124. Latin America Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 125. Latin America Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 126. Latin America Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 127. Latin America Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 128. Latin America Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 129. Latin America Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 130. Latin America Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 131. Latin America Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 132. Latin America Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. Europe Latent AMR Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Europe Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 135. Europe Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 136. Europe Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 137. Europe Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 138. Europe Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 139. Europe Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 140. Europe Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 141. Europe Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 142. Europe Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 143. Europe Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 144. Middle East Latent AMR Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Middle East Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 146. Middle East Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 147. Middle East Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 148. Middle East Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 149. Middle East Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 150. Middle East Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 151. Middle East Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 152. Middle East Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 153. Middle East Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 154. Middle East Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 155. Africa Latent AMR Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Africa Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 157. Africa Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 158. Africa Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 159. Africa Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 160. Africa Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 161. Africa Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 162. Africa Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 163. Africa Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 164. Africa Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 165. Africa Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. Global Latent AMR Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. ASEAN Latent AMR Market Size, by Group, 2017-2032 (USD Million)
TABLE 168. ASEAN Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 169. ASEAN Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 170. ASEAN Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 171. ASEAN Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 172. ASEAN Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 173. ASEAN Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 174. ASEAN Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 175. ASEAN Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. ASEAN Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 177. ASEAN Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. GCC Latent AMR Market Size, by Group, 2017-2032 (USD Million)
TABLE 179. GCC Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 180. GCC Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 181. GCC Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 182. GCC Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 183. GCC Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 184. GCC Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 185. GCC Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 186. GCC Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. GCC Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 188. GCC Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. European Union Latent AMR Market Size, by Group, 2017-2032 (USD Million)
TABLE 190. European Union Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 191. European Union Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 192. European Union Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 193. European Union Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 194. European Union Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 195. European Union Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 196. European Union Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 197. European Union Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 198. European Union Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 199. European Union Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. BRICS Latent AMR Market Size, by Group, 2017-2032 (USD Million)
TABLE 201. BRICS Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 202. BRICS Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 203. BRICS Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 204. BRICS Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 205. BRICS Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 206. BRICS Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 207. BRICS Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 208. BRICS Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 209. BRICS Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 210. BRICS Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. G7 Latent AMR Market Size, by Group, 2017-2032 (USD Million)
TABLE 212. G7 Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 213. G7 Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 214. G7 Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 215. G7 Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 216. G7 Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 217. G7 Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 218. G7 Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 219. G7 Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 220. G7 Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 221. G7 Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. NATO Latent AMR Market Size, by Group, 2017-2032 (USD Million)
TABLE 223. NATO Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 224. NATO Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 225. NATO Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 226. NATO Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 227. NATO Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 228. NATO Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 229. NATO Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 230. NATO Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 231. NATO Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 232. NATO Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 233. Global Latent AMR Market Size, by Country, 2017-2032 (USD Million)
TABLE 234. United States Latent AMR Market Size, 2017-2032 (USD Million)
TABLE 235. United States Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 236. United States Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 237. United States Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 238. United States Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 239. United States Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 240. United States Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 241. United States Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 242. United States Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 243. United States Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 244. United States Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. Canada Latent AMR Market Size, 2017-2032 (USD Million)
TABLE 246. Canada Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 247. Canada Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 248. Canada Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 249. Canada Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 250. Canada Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 251. Canada Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 252. Canada Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 253. Canada Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 254. Canada Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 255. Canada Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 256. Mexico Latent AMR Market Size, 2017-2032 (USD Million)
TABLE 257. Mexico Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 258. Mexico Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 259. Mexico Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 260. Mexico Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 261. Mexico Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 262. Mexico Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 263. Mexico Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 264. Mexico Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 265. Mexico Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 266. Mexico Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 267. Brazil Latent AMR Market Size, 2017-2032 (USD Million)
TABLE 268. Brazil Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 269. Brazil Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 270. Brazil Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 271. Brazil Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 272. Brazil Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 273. Brazil Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 274. Brazil Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 275. Brazil Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 276. Brazil Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 277. Brazil Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 278. United Kingdom Latent AMR Market Size, 2017-2032 (USD Million)
TABLE 279. United Kingdom Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 280. United Kingdom Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 281. United Kingdom Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 282. United Kingdom Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 283. United Kingdom Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 284. United Kingdom Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 285. United Kingdom Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 286. United Kingdom Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 287. United Kingdom Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 288. United Kingdom Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 289. Germany Latent AMR Market Size, 2017-2032 (USD Million)
TABLE 290. Germany Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 291. Germany Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 292. Germany Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 293. Germany Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 294. Germany Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 295. Germany Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 296. Germany Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 297. Germany Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 298. Germany Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 299. Germany Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 300. France Latent AMR Market Size, 2017-2032 (USD Million)
TABLE 301. France Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 302. France Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 303. France Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 304. France Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 305. France Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 306. France Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 307. France Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 308. France Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 309. France Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 310. France Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 311. Russia Latent AMR Market Size, 2017-2032 (USD Million)
TABLE 312. Russia Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 313. Russia Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 314. Russia Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 315. Russia Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 316. Russia Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 317. Russia Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 318. Russia Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 319. Russia Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 320. Russia Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 321. Russia Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 322. Italy Latent AMR Market Size, 2017-2032 (USD Million)
TABLE 323. Italy Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 324. Italy Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 325. Italy Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 326. Italy Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 327. Italy Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 328. Italy Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 329. Italy Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 330. Italy Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 331. Italy Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 332. Italy Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 333. Spain Latent AMR Market Size, 2017-2032 (USD Million)
TABLE 334. Spain Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 335. Spain Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 336. Spain Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 337. Spain Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 338. Spain Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 339. Spain Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 340. Spain Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 341. Spain Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 342. Spain Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 343. Spain Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 344. China Latent AMR Market Size, 2017-2032 (USD Million)
TABLE 345. China Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 346. China Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 347. China Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 348. China Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 349. China Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 350. China Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 351. China Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 352. China Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 353. China Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 354. China Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 355. India Latent AMR Market Size, 2017-2032 (USD Million)
TABLE 356. India Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 357. India Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 358. India Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 359. India Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 360. India Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 361. India Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 362. India Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 363. India Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 364. India Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 365. India Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 366. Japan Latent AMR Market Size, 2017-2032 (USD Million)
TABLE 367. Japan Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 368. Japan Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 369. Japan Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 370. Japan Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 371. Japan Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 372. Japan Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 373. Japan Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 374. Japan Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 375. Japan Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 376. Japan Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 377. Australia Latent AMR Market Size, 2017-2032 (USD Million)
TABLE 378. Australia Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 379. Australia Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 380. Australia Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 381. Australia Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 382. Australia Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 383. Australia Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 384. Australia Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 385. Australia Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 386. Australia Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 387. Australia Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 388. South Korea Latent AMR Market Size, 2017-2032 (USD Million)
TABLE 389. South Korea Latent AMR Market Size, by Technology, 2017-2032 (USD Million)
TABLE 390. South Korea Latent AMR Market Size, by Genotypic, 2017-2032 (USD Million)
TABLE 391. South Korea Latent AMR Market Size, by Phenotypic, 2017-2032 (USD Million)
TABLE 392. South Korea Latent AMR Market Size, by Product, 2017-2032 (USD Million)
TABLE 393. South Korea Latent AMR Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 394. South Korea Latent AMR Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 395. South Korea Latent AMR Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 396. South Korea Latent AMR Market Size, by Application, 2017-2032 (USD Million)
TABLE 397. South Korea Latent AMR Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 398. South Korea Latent AMR Market Size, by End User, 2017-2032 (USD Million)
TABLE 399. Global Latent AMR Market Share, by Key Player, 2025
TABLE 400. Global Latent AMR Market, Key Experts

Companies Mentioned

  • ABB Ltd.
  • Aclara RF Systems LLC
  • Averna Technologies Inc.
  • CalAmp Corp.
  • Cisco Systems, Inc.
  • EDMI Limited
  • Elster Group GmbH
  • Hexing Electrical Co., Ltd.
  • Honeywell International Inc.
  • Huawei Technologies Co., Ltd.
  • IBM Corporation
  • Itron, Inc.
  • Kamstrup A/S
  • Landis+Gyr Group AG
  • Nokia Corporation
  • Oracle America, Inc.
  • Schneider Electric SE
  • Secure Meters Ltd.
  • Siemens AG
  • Toshiba Digital Solutions Corporation
  • Trilliant Holdings Inc.
  • Wasion Group Holdings Limited
  • Xylem Inc.
  • ZTE Corporation

Related Topics

Related Reports

Mycobacterium Tuberculosis Test Kit Market - Global Forecast 2026-2032 - Product Image

Mycobacterium Tuberculosis Test Kit Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Latent TB Testing Market - Global Forecast 2026-2032 - Product Image

Latent TB Testing Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Latent TB Testing Market (2026 Edition) - Product Image

Latent TB Testing Market (2026 Edition)

  • Report
  • 198 Pages
  • Global
From
Latent Tuberculosis Infection Detection Market Size, Share & Trends Analysis Report by Brand, Test, Application, End Use, Region, and Segment Forecasts, 2026-2033 - Product Image

Latent Tuberculosis Infection Detection Market Size, Share & Trends Analysis Report by Brand, Test, Application, End Use, Region, and Segment Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Latent Tuberculosis Infection Detection Market Outlook 2026-2034: Market Share, and Growth Analysis by Test Method (Tuberculin Skin Test (TST), Interferon-Gamma Release Assays (IGRA), Other Emerging Tests), Sample Type, Technology, End-User - Product Image

Latent Tuberculosis Infection Detection Market Outlook 2026-2034: Market Share, and Growth Analysis by Test Method (Tuberculin Skin Test (TST), Interferon-Gamma Release Assays (IGRA), Other Emerging Tests), Sample Type, Technology, End-User

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.